companydata.dkcompanydata.dk

NOVO NORDISK PHARMACEUTICALS A/S: Financial statements 2020

CVR: 24257924

Source: annual report 2020, Danish Business Authority

01/01/2020 – 31/12/2020

NOVO NORDISK PHARMACEUTICALS A/S (CVR 24257924) has filed annual accounts for 2020. In 2020, the company reported a net result of DKK -2,368,000 compared with DKK 3,722,000 the year before. Equity in the 2020 report amounted to DKK 2,849,704,000. The solvency ratio was 96.3%.

Profit/Loss
DKK -2,368,000
Equity
DKK 2,849,704,000
Total Assets
DKK 2,958,624,000

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2020---2.4M2.8B-
2019--3.7M15.6M-
2018---2M11.8M-
2017---2.3M13.8M-
2016--1.7M16.1M-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is NOVO NORDISK PHARMACEUTICALS A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2020

Linette Tangsgaard Nielsen joins the board of NOVO NORDISK PHARMACEUTICALS A/SDec 15, 2020

As of December 15, 2020, Linette Tangsgaard Nielsen has joined the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.

Lene Moth Bang leaves the board of NOVO NORDISK PHARMACEUTICALS A/SDec 15, 2020

As of December 15, 2020, Lene Moth Bang has left the board of directors of NOVO NORDISK PHARMACEUTICALS A/S.

NOVO NORDISK PHARMACEUTICALS A/S: The 2019 annual report is outJun 2, 2020

NOVO NORDISK PHARMACEUTICALS A/S has published its annual report for 2019. The net result was DKK 3,722,000.

About NOVO NORDISK PHARMACEUTICALS A/S

NOVO NORDISK PHARMACEUTICALS A/S is a Danish company of the type Aktieselskab based in Bagsværd, founded in 1974. The company is registered under the industry Anden finansiel formidling i.a.n.. The company was previously named NOVO FARMAKA A/S. The management consists of Anders Rytter Mikkelsen. The board consists of Naja Eilers Barrisøe (chair), Linette Tangsgaard Nielsen and Thomas Rask Nielsen. The company is owned by NOVO NORDISK A/S. According to the 2025 annual report, the company had an average of 0 employees. In 2025, the company reported a gross profit of DKK -53,000 and a net result of DKK 2,074,000 compared with DKK 6,918,000 the year before. Equity in the 2025 report amounted to DKK 12,325,000.

Source: annual report 2025, Danish Business Authority